PDS Biotechnology Corp

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

PDSB

organization

SIC: 2834

SEC Insider

$31.8M

336 transactions

Summary

PDS Biotechnology Corp (PDSB) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $15.6MSales: $1.5M38 insiders

Date	Insider	Type	Value
2026-01-12	Glover Stephen C.	A	$0
2026-01-12	BRAWLEY OTIS W	A	$0
2026-01-12	Ali-Jackson Kamil	A	$0
2026-01-12	Iliev Ilian	A	$0
2026-01-12	Freitag Gregory Gene	A	$0
2026-01-12	Toutain Stephan(Chief Operating Officer)	A	$0
2026-01-12	Brown Spencer D.(Senior VP, General Counsel)	A	$0
2026-01-12	Boesgaard Lars(Chief Financial Officer)	A	$0
2026-01-12	Shepard Kirk V.(Chief Medical Officer)	A	$0
2026-01-12	CONN GREGORY(Chief Scientific Officer)	A	$0
2026-01-12	BEDU-ADDO FRANK(President/CEO)	A	$0
2025-06-12	Toutain Stephan(Chief Operations Officer)	A	$0
2025-06-12	CONN GREGORY(Chief Scientific Officer)	A	$0
2025-06-12	Boesgaard Lars(Chief Financial Officer)	A	$0
2025-06-12	Brown Spencer D.(Senior VP, General Counsel)	A	$0
2025-06-12	Shepard Kirk V.(Chief Medical Officer)	A	$0
2025-06-12	BEDU-ADDO FRANK(President/CEO)	A	$0
2025-06-11	Glover Stephen C.	A	$0
2025-06-11	Freitag Gregory Gene	A	$0
2025-06-11	Ali-Jackson Kamil	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

PDS Biotechnology Corp — Contributions, Lobbying & Contracts | Poliscope